EPO Patents = 1

Forward Citations = 0

Loading Chart...

20 inventors (with patents filed for the assignee):

Zengquan Wang (4 out of 4 patents)

Yang Wang (3 out of 14 patents)

Wenkui Ken Fang (2 out of 2 patents)

4. Chen Mao (1 out of 4 patents)

5. Sheldon Cao (1 out of 20 patents)

6. Wenhao Zhu (1 out of 1 patent)

7. Xiang Pan (1 out of 1 patent)

8. Guanqun Li (1 out of 1 patent)

9. Xiaolei Wang (1 out of 1 patent)

10. Yuting Cai (1 out of 1 patent)

11. Li Xing (1 out of 1 patent)

12. Xiang Jiang (1 out of 1 patent)

13. Guanqun Li (1 out of 1 patent)

14. Yuting Cai (1 out of 1 patent)

15. Xiang Pan (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 12643866 - Small molecule compound serving as JAK kinase inhibitor and use thereof (2026-06-02),

2. 12552780 - Small molecule compound serving as jak kinase inhibitor, and use thereof (2026-02-17),

3. 12509447 - Small molecule compound (2025-12-30),

4. 9920022 - Small molecule compound and synthesizing method and uses thereof (2018-03-20),

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#17 in Jiaxing

#6,438 in China

Jiaxing, China

Technoderma Medicines Pte Ltd.

Forward Citations = 0

20 inventors:

Zengquan Wang (4 out of 4 patents)

Yang Wang (3 out of 14 patents)

Wenkui Ken Fang (2 out of 2 patents)

4. Chen Mao (1 out of 4 patents)

5. Sheldon Cao (1 out of 20 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Technoderma Medicines Pte Ltd.. Retrieved from https://idiyas.com/company/technoderma-medicines

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]